Inclusion complexation of diclofenac with natural and modified cyclodextrins explored through phase solubility, 1H-NMR and molecular modeling studies

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 57, Issue 1-4, 2007, Pages 503-510

  Abdoh, A A ^a   Zughul, M B ^b   Davies, J Eric D ^c   Badwan, A A ^a  

^a JORDANIAN PHARMACEUTICAL MANUFACTURING COMPANY   (Jordan)

^b UNIVERSITY OF JORDAN   (Jordan)

^c LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

1H NMR; Complexation; Cyclodextrin; Diclofenac; Molecular modeling; pH Solubility profiles; Phase solubility diagrams; pKa

Indexed keywords

EID: 34047218729     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-006-9241-8     Document Type: Conference Paper

References (28)

1. Duchene, D.: New Trends in Cyclodextrins and Derivatives, pp. 231-407. Editions de Sante, Paris (1992)
2. Stella, V.J., Rajewski, R.A.: Cyclodextrins: their future in drug formulation and delivery. Pharm. Res. 14, 556-567 (1997)
3. Arancibia, J.A., Boldrini, M.A., Escandar, G.M.: Spectro-fluorimetric determination of diclofenec in the presence of α-cyclodexrin. Talanta 52(2), 261-268 (2000)
4. Pose-Vilarnovo, B., Sanata-Penin, L., Echezarreta-Lopez, M., Perez-Marcos, M.B., Vila-Jato, J.L., Torres-Labandeira, J.J.: Interaction of diclofenac with β- and hydroxypropyl-β-cyclodextrin in solution. STP Pharma. Sci. 9(3), 231-236 (1999)
5. Arancibia, J.A., Escander, G.M.: Complexation study of diclofenac with β-cyclodextrin and spectrofluometric determination. Analyst 124, 1833-1838 (1999)
6. Orienti, I., Fini, A., Bertasi, V., Zecchi, V.: Inclusion complexes between nonsteroidal antiinflamatory drugs and β-cyclodextrin. Eur. J. Pharm. Biopharm. 37, 110-112 (1991)
7. Manca, M.L., Zaru, M., Ennas, G., Valenti, D., Sinico, C., Loy, G., Fadda, A.M.: Diclofenac-β-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and difusión studies. AAPS Pharm. Sci. Tech. 6(3), E464-E472 (2005)
8. Bogdan, M., Caira, M.R., Bogdan, D., Morari, C., Fracas, S.I.: Evidence of a bimodal binding between diclofenac-Na and β-cyclodextrin in solution.J. Inclus. Phenom. Macromol. Chem. 49, 225-229 (2004)
9. Barbato, F., Capello, B., La Rotonda, M.I., Miro, A., Quaglia, F.: Diclofenac/β-cyclodextrin binary systems: A study in solution and in the solid state. J. Inclus. Phenom. Macromol. Chem. 46(3-4), 179-185 (2003)
10. Shamsipur, M., Jalali, F., Ershad, S.: Preparation of a diclofenac potentiometric sensor and its application to pharmaceutical analysis and to drug recovery from biological fluids. J. Phar. Biomed. Analysis, 37, 943-947 (2005)
11. Wei, W., Ju, H.X.: Affinity capillary electrophoresis studies on the influence of alcohols on the interaction of β-cyclodextrin with nonsteroidal antiinflammatory drugs. Chromatographia, 58(7-8), 449-453 (2003)
12. 13C NMR study on diclofenac/β-cyclodextrin and diclofenac/ 2-hydroxypropyl- β-cyclodextrin systems. J. Chem. Res. (M), 1761-1795 (1999)
13. Pose-Vilarnovo, B., Sanchez, C.R.-T., Mourse, N.D., Vila-Jato, J.L., Torres-Labandeira, J.J.: Effect of hydroxypropylmethyl cellulose on the complexation of diclofenac with cyclodextrins. J. Thermal Anal. Calorimetry 73, 661-670 (2003)
14. Fischer, W., Sendl-Lang, A.: Diclofenac-γ-cyclodextrin inclusion compounds for oral dosage forms. Patent No. WO 9735568 A2, Application No. WO 1997-EP1595 (1997)
15. Takeuchi, M., Maruyama, H., Suzuzi, H., Oguma, T., Meada, M.: Antiinflamatory eyedrops. Patent No. WO 9622088 A1, Application No. 95-JP2680 19951226 (1996)
16. 1H-NMR and molecular modeling studies. J. Inclus. Phenom. Macromol. Chem. 41, 857-865 (2006)
17. Higuchi, T., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Instr. 4, 117-212 (1965)
18. 2-type phase solubility diagrams, complex formation and chemical speciation of soluble species. J. Incl. Phenom. Mol. Recog. Chem. 31, 243-264 (1998)
19. 2L-type complexes. Int. J. Pharm. 151, 109-119 (1997)
20. Zughul, M.B., Al-Omari, M., Badwan, A.A.: Thermodynamics of propyl paraben/β-cyclodextrin inclusion complexes. Pharm. Dev. Tech. 3, 43-53 (1998)
21. Puliti, R., Mattia, C.A., Paduano, L.: Crystal structure of a new alpha-cyclodextrin hydrate form. Molecular geometry and packing features: disordered solvent contribution. Carbohydr. Res. 310, 1-8 (1998)
22. Linder, K., Saenger, W.: Topography of cyclodextrin complexes. Part XVII. Crystal and molecular structure of cycloheptaamylose dodecahydrate. Carbohydr. Res. 99, 103-115 (1982)
23. Saenger, W., Jacob, J., Gessler, K., Steiner, T., Hoffman, D., Sanbe, H., Koizumi, K., Smith, S.M., Takaha, T.: Structures of the common cyclodextrins and their larger analogues-beyond the doughnut. Chem. Rev. 98, 1787-1802 (1998)
24. Harata, K.: The structure of the cyclodextrin complex. XX. Crystal structure of uncomplexed hydrated β-cyclodextrin. Bull. Chem. Soc. Jpn. 60, 2763 (1987)
25. Whittaker, D.V., Penkler, L.J., Glintenkamp, L.A., Bosh Van Oudtshoorn, M.C., Wessels, P.L.: Diclofenac-β-cyclodextrin inclusion in solution proton magnetic resonance and molecular modeling studies. J. Inclus. Phenom. Mol. Recogn. Chem. 25(1-3), 177-180 (1996)
26. 13C NMR study on diclofenac/β-cyclodextrin and diclofenac/ 2-hydroxypropyl- β-cyclodextrin systems. J. Chem. Res. (S), 414-415 (1999)
27. 1H-NMR and molecular modeling study on the inclusion complex b-cyclodextrin-indomethacin. J. Org. Chem. 61, 909-914 (1996)
28. Oh, I., Lee, M., Lee, Y., Shin, S., Park, I.: Spectroscopic characterization of ibuprofen/2-hydroxypropyl-β-cyclodextrin inclusion complex. Int. J. Pharm. 175, 215-223 (1998)